首页> 美国卫生研究院文献>PLoS Clinical Trials >Steps to achieve quantitative measurements of microRNA using two step droplet digital PCR
【2h】

Steps to achieve quantitative measurements of microRNA using two step droplet digital PCR

机译:使用两步液滴数字PCR实现MicroRNA定量测量的步骤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Droplet digital PCR (ddPCR) is being advocated as a reference method to measure rare genomic targets. It has consistently been proven to be more sensitive and direct at discerning copy numbers of DNA than other quantitative methods. However, one of the largest obstacles to measuring microRNA (miRNA) using ddPCR is that reverse transcription efficiency depends upon the target, meaning small RNA nucleotide composition directly effects primer specificity in a manner that prevents traditional quantitation optimization strategies. Additionally, the use of reagents that are optimized for miRNA measurements using quantitative real-time PCR (qRT-PCR) appear to either cause false positive or false negative detection of certain targets when used with traditional ddPCR quantification methods. False readings are often related to using inadequate enzymes, primers and probes. Given that two-step miRNA quantification using ddPCR relies solely on reverse transcription and uses proprietary reagents previously optimized only for qRT-PCR, these barriers are substantial. Therefore, here we outline essential controls, optimization techniques, and an efficacy model to improve the quality of ddPCR miRNA measurements. We have applied two-step principles used for miRNA qRT-PCR measurements and leveraged the use of synthetic miRNA targets to evaluate ddPCR following cDNA synthesis with four different commercial kits. We have identified inefficiencies and limitations as well as proposed ways to circumvent identified obstacles. Lastly, we show that we can apply these criteria to a model system to confidently quantify miRNA copy number. Our measurement technique is a novel way to quantify specific miRNA copy number in a single sample, without using standard curves for individual experiments. Our methodology can be used for validation and control measurements, as well as a diagnostic technique that allows scientists, technicians, clinicians, and regulators to base miRNA measures on a single unit of measurement rather than a ratio of values.
机译:液滴数字PCR(ddPCR)被提倡作为测量稀有基因组靶标的参考方法。与其他定量方法相比,它一直被证明对识别DNA的拷贝数更为敏感和直接。但是,使用ddPCR测量microRNA(miRNA)的最大障碍之一是逆转录效率取决于靶标,这意味着小RNA核苷酸组成会以防止传统定量优化策略的方式直接影响引物特异性。此外,与传统的ddPCR定量方法一起使用时,使用针对使用定量实时PCR(qRT-PCR)进行miRNA测量而优化的试剂的使用似乎会导致某些目标的假阳性或假阴性检测。错误的读数通常与使用不足的酶,引物和探针有关。鉴于使用ddPCR进行的两步miRNA定量仅依赖于逆转录,并且使用了先前仅针对qRT-PCR优化的专有试剂,因此这些障碍非常重要。因此,这里我们概述了必要的控制,优化技术和功效模型,以提高ddPCR miRNA测量的质量。我们已经应用了用于miRNA qRT-PCR测量的两步原理,并利用合成的miRNA靶标使用四种不同的商业试剂盒进行cDNA合成后评估ddPCR。我们已经确定了效率低下和局限性,并提出了一些方法来规避已发现的障碍。最后,我们证明了我们可以将这些标准应用于模型系统,以可靠地量化miRNA的拷贝数。我们的测量技术是一种定量单个样品中特定miRNA拷贝数的新颖方法,而无需为单个实验使用标准曲线。我们的方法学可用于验证和控制测量,以及一种诊断技术,该技术可使科学家,技术人员,临床医生和监管人员将miRNA度量基于单个度量单位而不是值的比率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号